Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

Share Price is delayed by 15 minutes
Get Live Data
808.00    10.00 (1.25%)
Bid:
806.00
Ask:
807.50
Spread: 1.50 (0.186%)
Market Cap: £1.63b
DNLM Live PriceLast checked at - London Stock Exchange

Intraday Dunelm Share Chart

Director/PDMR Shareholding

19 Sep 2008 13:36

RNS Number : 8672D
Dunelm Group plc
19 September 2008
 



19 September 2007

Grant of conditional awards over ordinary shares to Directors under the 2008/2009 Long Term Incentive Programme (LTIP)

Conditional awards over ordinary shares in Dunelm Group plc in the form of a nil cost option have been granted to Will Adderley, Chief Executive and David Stead, Finance Director, under the 2008/2009 LTIP on 18 September 2008.

The maximum award under the LTIP is 120% of basic salary for each executive director. This will vest, subject to the performance conditions, following publication of results for the year to 30 June 2011

Using a closing mid price on 18 September 2008 of 148p, awards have been granted as follows:

Will Adderley: conditional award over 259,459 shares

Basic salary

Basic x 120%

Share price

No. of shares under award

Total no. of options held

£320,000

£384,000

£1.48

259,459

607,007

David Stead: conditional award over 178,378 shares

Basic salary

Basic x 120%

Share price

No. of shares under award

Total no. of options held

£220,000

£264,000

£1.48

178,378

411,476

- Ends -

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFKCKNBBKDQCD
Date   Source Headline
5th Oct 20187:00 amRNSBlock listing Interim Review
5th Oct 20187:00 amRNSBlock listing Interim Review
5th Oct 20187:00 amRNSBlock listing Interim Review
12th Sep 20187:00 amRNSFinal Results
29th Aug 20187:00 amRNSBoard Changes
23rd Aug 201810:49 amRNSDirector Declaration
2nd Aug 20189:41 amRNSHolding(s) in Company
23rd Jul 20187:00 amRNSDirector/PDMR Shareholding
13th Jul 201810:51 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSYear-end Trading Update
29th May 20187:00 amRNSDirector/PDMR Shareholding
25th May 201811:56 amRNSTrading Update
18th May 20187:00 amRNSAppointment of Chief Financial Officer
12th Apr 20187:00 amRNSThird Quarter Trading Update
10th Apr 20187:00 amRNSBlock listing Interim Review
10th Apr 20187:00 amRNSBlock listing Interim Review
10th Apr 20187:00 amRNSBlock listing Interim Review
10th Apr 20187:00 amRNSBlock listing Interim Review
3rd Apr 20187:00 amRNSConfirmation of appointment of Rachel Osborne
23rd Mar 20188:28 amRNSTR-1
23rd Mar 20187:00 amRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSTotal Voting Rights
22nd Feb 20187:00 amRNSDirector/PDMR Shareholding
20th Feb 20187:00 amRNSDirectorate Change
20th Feb 20187:00 amRNSInterim Results
1st Feb 20187:00 amRNSConfirmation of appointment of Nick Wilkinson
31st Jan 20187:00 amRNSTotal Voting Rights
19th Jan 201810:37 amRNSHolding(s) in Company
19th Jan 201810:33 amRNSHolding(s) in Company
19th Jan 20187:00 amRNSDirector/PDMR Shareholding
17th Jan 201811:10 amRNSHolding(s) in Company
16th Jan 20187:00 amRNSSecond Quarter Trading Update
29th Dec 20177:00 amRNSTotal Voting Rights
21st Dec 20177:00 amRNSAppointment of Chief Executive
8th Dec 201710:13 amRNSDirector/PDMR Shareholding
21st Nov 201711:57 amRNSResult of AGM
20th Nov 20177:00 amRNSDirectorate Change
3rd Nov 20177:00 amRNSBlock listing Interim Review
3rd Nov 20177:00 amRNSBlock listing Interim Review
3rd Nov 20177:00 amRNSBlock listing Interim Review
3rd Nov 20177:00 amRNSBlock listing Interim Review
18th Oct 20177:00 amRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSAnnual Financial Report
11th Oct 20177:00 amRNSTrading Update and Capital Markets Event
2nd Oct 201711:35 amRNSHolding(s) in Company
29th Sep 20177:00 amRNSTotal Voting Rights
25th Sep 20171:50 pmRNSHolding(s) in Company
20th Sep 20177:00 amRNSDirector/PDMR Shareholding
13th Sep 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.